Skip to main content
Shane E. Brogan
( out of 75 reviews )

Shane E. Brogan, MD

Languages spoken: Irish, English, French

Clinical Locations

University of Utah Hospital

Anesthesiology
Salt Lake City
801-581-6393
  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Board Certification

    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)

    Patient Rating

    4.9 /5
    ( out of 75 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 06, 2024
    HUNTSMAN CANCER CENTER

    Great doctor. Listens and finds solutions.

    October 05, 2024
    HUNTSMAN CANCER CENTER

    Very good and professional

    September 15, 2024
    HUNTSMAN CANCER CENTER

    Very amazing doctor and always willing to help and listen to whatever is needed for me and my comfort:)

    September 12, 2024
    HUNTSMAN CANCER CENTER

    Dr. Brogan always listens to my concerns and answers my questions. He is knowledgeable, caring, and supports me in achieving my pain management goals.

    July 30, 2024
    HUNTSMAN CANCER CENTER

    Dr Brogan is a kind, compassionate, competent physician. His care and competence has made my cancer journeymy much easier to travel.

    July 28, 2024
    HUNTSMAN CANCER CENTER

    When I first meet Dr Brogan I knew he was a very caring and understanding doctor. I have been seeing him for over 3 years, he has a great listening ear, his medical staff also care and listen. I recommend him.

    July 16, 2024
    HUNTSMAN CANCER CENTER

    compassionate and caring physician

    July 10, 2024
    HUNTSMAN CANCER CENTER

    He cares deeply about the outcome of his treatments

    June 13, 2024
    HUNTSMAN CANCER CENTER

    Great Doctor listen and is very understanding .

  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Board Certification and Academic Information

    Academic Departments Anesthesiology -Primary
    Board Certification
    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)

    Education history

    Fellowship Anesthesiology - University of Utah School of Medicine Fellow
    Anesthesiology - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Medical School - Royal College of Surgeons - Ireland M.B.B.Ch.

    Selected Publications

    Journal Article

    1. Gabay S, Sapir Y, Korn A, Hochberg U, Tellem R, Zegerman A, Brogan SE, Rahimpour S, Shofty B, Strauss I (2023). Optimization of Radiofrequency Needle Placement in Percutaneous Cordotomy Using Electromyography in the Deeply Sedated Patient. Oper Neurosurg (Hagerstown), 26(1), 22-27. (Read full article)
    2. Abdullah N, Sindt JE, Whittle J, Anderson JS, Odell DW, Mahan M, Brogan SE (2023). Impact of Neuromodulation on Opioid Use, Adjunct Medication Use, and Pain Control in Cancer-Related Pain: A Retrospective Case Series. Pain Med, epub ahead of print.
    3. Brogan SE, Sindt JE, Odell DW, Gulati A, Dupoiron D (2022). Controversies in intrathecal drug delivery for cancer pain. Reg Anesth Pain Med, 48(6), 319-325. (Read full article)
    4. Brogan SE, Odell DW, Sindt JE, Yi I, Chrisman OM, Zhang C, Presson AP (2022). Dorsal vs Ventral Intrathecal Catheter Tip Location and Effect on Dose Escalation and Opioid Use in Patients With Cancer Pain. Neuromodulation, 26(6), 1233-1239. (Read full article)
    5. Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan SE (2022). Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies. Neuromodulation. (Read full article)
    6. Sindt JE, Odell DW, Tariq R, Presson AP, Zhang C, Brogan SE (2021). Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio. Neuromodulation, 24(7), 1157-1166. (Read full article)
    7. Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, Singh V, Gulati A, Strand N, Weisbein J, Goree JH, Xing F, Valimahomed A, Pak DJ, El Helou A, Ghosh P, Shah K, Patel V, Escobar A, Schmidt K, Shah J, Varshney V, Rosenberg W, Narang S (2021). The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain. J Pain Res, 14, 2139-2164. (Read full article)
    8. Brogan SE, Sindt JE, Odell DW (2021). Quantitative Assessment of the Incidence of Persistent Orthostatic Hemodynamic Changes After Celiac Plexus Neurolysis: A Prospective Case Series. A A Pract, 15(5), e01470. (Read full article)
    9. Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao R (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208. (Read full article)
    10. Sindt JE, Odell DW, Dalley AP, Brogan SE (2020). Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer. Neuromodulation, 23(7), 978-983. (Read full article)
    11. Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A (2019). Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesth Analg, 130(4), 1035-1044. (Read full article)
    12. Brogan SE, Winter NB, Abiodun A, Safarpour R (2013). A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit. Pain Med, 14(4), 478-86. (Read full article)
    13. Brogan SE (2006). Intrathecal therapy for the management of cancer pain. Curr Pain Headache Rep, 10(4), 254-9. (Read full article)
    14. Brogan SE, Cahalan MK (2005). Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesth Analg, 101(3), 635-6, table of contents. (Read full article)

    Review

    1. Sindt JE, Fitzgerald LA, Kuznicki J, Prelewicz S, Odell DW, Brogan SE (2023). Antiplatelet and Wound Healing Implications of Immunotherapy and Targeted Cancer Therapies in the Perioperative Period. [Review]. Anesthesiology, 139(4), 511-522. (Read full article)